PLK4 and prostate cancer: This result is supported by other studies where Plk4 has been demonstrated to increase colony formation, as well as treatment of Plk4 inhibitor (CFI-400945) significantly reduces cell growth, viability and colony formation in human prostate cancer cells, in multiple embryonal tumor cell lines, and other cancers [41, 63–65].